HiFiBiO
Ang (Andy) Tu is a Principal Scientist in Computational Biology at HiFiBiO Therapeutics, leading a small team and focusing on the analysis of immunofluorescence data from clinical trials. Previous roles include Senior Computational Biologist at Immunai, where workflows for cloud-based imaging analysis were developed, and Senior Scientist at Immunitas Therapeutics, contributing to target discovery projects. Ang's academic background includes a PhD from the Massachusetts Institute of Technology, where research centered on high-throughput paired sequencing and T cell studies, complemented by a B.S. in Biomedical Engineering from The Johns Hopkins University. Early career experience includes co-founding a medical technology company and contributing to research projects at prestigious institutions such as Johns Hopkins and Los Angeles Biomedical Research Institute.
This person is not in any teams
HiFiBiO
HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease. The company integrates deep-rooted biological expertise with our comprehensive single-cell profiling technologies to rapidly discover and advance a pipeline of antibody drugs to treat cancer and autoimmune disorders. In addition, HiFiBiO Therapeutics aspires to benefit patients through open-innovation partnerships with industry and academia.